Conn's current therapy 1994. Conn HF, Rakel RE, ed. Philadelphia, PA: W. B. Saunders, 1994 Jan; :207-210
Link
NIOSHTIC No.
00232448
Abstract
The occupational risks, pathogenic mechanism, clinical manifestation, prevention and treatment of silicosis were reviewed and discussed. Alveolar macrophage interactions with inhaled silica (14808607) particles and subsequent formation of hyaline nodules were described. The increased reactivity of freshly fractured silica was mentioned. Chronic, complicated, accelerated and acute silicosis were described in terms of clinical symptoms, time from exposure to onset, and complications. The importance of prevention was emphasized in light of the limitations of current therapies. The need to report cases of silicosis was stressed as a means to protect other workers. Treatment of silicosis has mainly involved treating the complications associated with the condition. Treatment of airway obstruction with beta-2 adrenergic agents and theophylline was suggested. Aggressive antibiotic therapy with pathogen culturing and resistance assays for bronchial infections, including tuberculosis, was recommended. Hydration, humidification, postural drainage and particularly the cessation of smoking were recommended to reduce airway secretions. Supplemental oxygen was recommended in the treatment of hypoxemia. The use of whole lung lavage, glucocorticoid therapy and prednisone in acute silicosis was discussed. The seriousness of silicosis was underscored by the possible need for lung or heart/lung transplants in end stage silicosis. The author concludes that silica exposure prevention is critically important due to the lack of successful therapy for silicosis.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.